https://news.augustaheadlines.com/story/505282/aicardi-goutieres-syndrome-market-expected-to-rise-2034-icagen-gilead-sciences-eli-lilly-and-company-and-immunesensor-therapeutics-expected-to-drive-market.html 2025-02-11T09:34:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/505281/phild-market-on-track-for-major-expansion-by-2034-according-to-delveinsigh-insmed-incorporated-bellerophon-therapeutics-united-therapeutics-bayer-biogen.html 2025-02-11T09:26:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/505280/refractory-angina-market-to-reach-new-heights-in-growth-by-2034-delveinsight-predicts-gene-biotherapeutics-xylocor-therapeutics-centocor-lisata-therapeutics.html 2025-02-11T08:48:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/505279/alagille-syndrome-market-expected-to-rise-2034-mirum-pharmaceuticals-albireo-expected-to-drive-market.html 2025-02-11T08:36:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/505277/chronic-plaque-psoriasis-market-expected-to-rise-2034-dermavant-sciences-pfizer-arcutis-biotherapeutics-bms-merck-ucb-pharma-arbor-pharmaceuticals-dr-reddys-laboratories-kadmon-pharmaceut.html 2025-02-11T08:04:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/505276/hereditary-angioedema-market-expected-to-rise-2034-kalvista-pharmaceuticals-intellia-therapeutics-biomarin-pharmaceutical-expected-to-drive-market.html 2025-02-11T07:34:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/505275/hypertrophic-cardiomyopathy-treatment-market-2034-clinical-trials-ema-pdma-fda-approvals-medication-patient-pool-moa-roa-and-companies-by-delveinsight.html 2025-02-11T07:18:05+00:00 daily 1.0 https://news.augustaheadlines.com/story/505274/focal-segmental-glomerulosclerosis-fsgs-treatment-market-2034-clinical-trials-ema-pdma-fda-approvals-medication-patient-pool-moa-roa-and-companies-by-delveinsight.html 2025-02-11T07:04:04+00:00 daily 1.0 https://news.augustaheadlines.com/story/505273/lupus-nephritis-treatment-market-2034-clinical-trials-ema-pdma-fda-approvals-medication-prevalence-therapies-moa-roa-and-companies-by-delveinsight.html 2025-02-11T06:46:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/505272/gastrointestinal-stromal-tumor-gist-treatment-market-2034-clinical-trials-ema-pdma-fda-approvals-medication-patient-pool-moa-roa-and-companies-by-delveinsight.html 2025-02-11T06:44:02+00:00 daily 1.0